Nascent Biotech, Inc. (NBIO)

Nascent Biotech Statistics

Total Valuation

NBIO has a market cap or net worth of $8.61 million. The enterprise value is $8.36 million.

Market Cap	8.61M
Enterprise Value	8.36M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

NBIO has 172.20 million shares outstanding. The number of shares has increased by 29.47% in one year.

Shares Outstanding	172.20M
Shares Change (YoY)	+29.47%
Shares Change (QoQ)	+2.00%
Owned by Insiders (%)	48.96%
Owned by Institutions (%)	0.63%
Float	85.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.68

Current Ratio	0.68
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.08

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-378.12%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NBIO has paid $362,087 in taxes.

Income Tax	362,087
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.06% in the last 52 weeks. The beta is -3.19, so NBIO's price volatility has been lower than the market average.

Beta (5Y)	-3.19
52-Week Price Change	-28.06%
50-Day Moving Average	0.09
200-Day Moving Average	0.13
Relative Strength Index (RSI)	31.61
Average Volume (20 Days)	105,076

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-2
Operating Income	-2.23M
Pretax Income	-2.09M
Net Income	-2.09M
EBITDA	-2.23M
EBIT	-2.46M
Earnings Per Share (EPS)	-$0.01

Balance Sheet

The company has $372,120 in cash and $122,500 in debt, giving a net cash position of $249,620 or $0.00 per share.

Cash & Cash Equivalents	372,120
Total Debt	122,500
Net Cash	249,620
Net Cash Per Share	$0.00
Equity (Book Value)	-256,674
Book Value Per Share	-0.00
Working Capital	-256,674

Cash Flow

Operating Cash Flow	-1.19M
Capital Expenditures	n/a
Free Cash Flow	-1.19M
FCF Per Share	-$0.01

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.47%
Shareholder Yield	-29.47%
Earnings Yield	-24.25%
FCF Yield	-13.78%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2